Angiomyolipoma ultrasound

	Angiomyolipoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Angiomyolipoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Angiomyolipoma ultrasound On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Angiomyolipoma ultrasound All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Angiomyolipoma ultrasound
CDC on Angiomyolipoma ultrasound
Angiomyolipoma ultrasound in the news
Blogs on Angiomyolipoma ultrasound
Directions to Hospitals Treating Angiomyolipoma
Risk calculators and risk factors for Angiomyolipoma ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]Faizan Sheraz, M.D. [3]

Ultrasound

tend to appear as hyperechoic lesions on ultrasound, located in the cortex and with posterior acoustic shadowing
in the setting of tuberous sclerosis, they may be so numerous that the entire kidney is affected, appearing echogenic with loss of normal cortico-medullary differentiation
contrast-enhanced ultrasound
- tend to enhance peripherally
- decreased central enhancement, compared with normal cortex

USG images demonstrate a large kidney angiomyolipoma